A series of substituted fused bicyclic imidazole derivatives of formula (I), including benzimidazole derivatives and analogues thereof, being potent modulators of human IL-17 activity, are accordingly of benefit in the treatment and/or prevention of various human ailments including inflammatory and autoimmune disorders, wherein i. a. A represents C—R1 or N; B represents C—R2 or N; D represents C—R3 or N; E represents C—R4 or N; Z represents —CH(R5)N(H)CH2R6, —CH(R5)N(H)S(O)2R6, —C(═CR5aR5b)N(H)C(O)R6, —CH(R5)R7, —CH(R5)N(H)R7 or —CH(R5)C(O)N(H)R7; R0 represents hydrogen or C1-6 alkyl.


    Access

    Download


    Export, share and cite



    Title :

    Therapeutic agents


    Publication date :

    2019-08-07


    Type of media :

    Patent


    Type of material :

    Electronic Resource


    Language :

    English



    LIPOPROTEIN NANOPLATFORM FOR TARGETED DELIVERY OF DIAGNOSTIC AND THERAPEUTIC AGENTS

    Glickson, J.D. / Lund-Katz, S. / Zhou, R. et al. | British Library Conference Proceedings | 2008



    THERAPEUTIC TECHNOLOGY FUSION

    MIGNECO FRANCESCO / GALLAGHER DAVID | European Patent Office | 2021

    Free access

    Therapeutic technology fusion

    MIGNECO FRANCESCO / GALLAGHER DAVID | European Patent Office | 2021

    Free access

    THERAPEUTIC TECHNOLOGY FUSION

    MIGNECO FRANCESCO / GALLAGHER DAVID | European Patent Office | 2021

    Free access